Nascis regimen 10 marks pg Orthopaedic answer include flow chart and images

Reading File

Finding Sources

Searching PubMed

NASCIS methylprednisolone spinal cord injury

Reading File

Loading Image

Searching the Web

NASCIS regimen methylprednisolone spinal cord injury protocol flowchart 24 hours 48 hours

Loading Image

I now have all the content needed for a comprehensive 10-mark PG Orthopaedics answer. Let me compile the full answer.

NASCIS Regimen in Acute Spinal Cord Injury

Introduction

The National Acute Spinal Cord Injury Studies (NASCIS) were a series of three landmark prospective, double-blind, randomized controlled trials conducted in the 1990s that evaluated the role of high-dose methylprednisolone sodium succinate (MPSS) in acute blunt spinal cord injury (SCI). They remain the most comprehensive pharmacological trials in the history of SCI research.

Rationale / Mechanism of Action

Methylprednisolone is believed to exert neuroprotection via:

Inhibition of free-radical-induced lipid peroxidation (primary mechanism) - prevents secondary injury cascade
Increases spinal cord blood flow
Increases extracellular calcium levels
Prevents loss of potassium from injured cord tissue
Crosses cell membranes more rapidly and completely than other steroids (hence preferred over dexamethasone)

The secondary injury cascade after primary SCI proceeds as: Mechanical trauma → Local edema → Cellular apoptosis → Disorganized fibrosis → Hindered neuronal signaling & axonal regrowth

Pharmacologic therapy aims to halt or reverse this cascade.

Spinal Cord Anatomy - Relevant to SCI Understanding

Spinal cord injury patterns - tracts and syndromes (Schwartz's Principles of Surgery)

Spinal cord cross-section anatomy showing key tracts and injury patterns - Schwartz's Principles of Surgery

Incomplete spinal cord injury syndromes (Miller's Review of Orthopaedics)

Incomplete SCI syndromes - Central cord, Anterior cord, Brown-Sequard, Posterior cord - Miller's Review of Orthopaedics

The Three NASCIS Trials

Trial	Comparison Arms	n	Primary Result	Post-Hoc Finding
NASCIS I	Low-dose MPSS (100 mg bolus/day) vs High-dose MPSS (1000 mg bolus/day)	330	No difference in outcomes	-
NASCIS II	High-dose MPSS vs Naloxone vs Placebo	427	Negative (primary outcome)	Modest motor improvement if MPSS given within 8 hours
NASCIS III	MPSS 24h vs MPSS 48h vs Tirilazad mesylate 48h	499	Negative (primary outcome)	Extended 48h regimen improved outcomes if started 3-8 hours post injury

NASCIS II Protocol (The Classic Regimen)

Indications:

Blunt trauma with neurologic deficit referable to the spinal cord
Treatment started within 8 hours of injury

NASCIS II Dosing Protocol

┌─────────────────────────────────────────────────────────────┐
│                    NASCIS II PROTOCOL                       │
│                                                             │
│  STEP 1: Loading Bolus                                      │
│  Methylprednisolone 30 mg/kg IV over 15 minutes            │
│                        ↓                                    │
│  STEP 2: Pause                                              │
│           Wait 45 minutes                                   │
│                        ↓                                    │
│  STEP 3: Maintenance Infusion                               │
│  Methylprednisolone 5.4 mg/kg/hr IV for 23 hours           │
│                                                             │
│  TOTAL DURATION = 24 hours                                  │
└─────────────────────────────────────────────────────────────┘

NASCIS III Protocol (Time-Stratified Regimen)

NASCIS III refined the duration based on time from injury:

FLOWCHART: NASCIS Regimen Decision Algorithm

┌─────────────────────────────────────────────────────────────────────┐
│            ACUTE BLUNT SPINAL CORD INJURY                           │
│            (Neurologic deficit present)                             │
└───────────────────────────┬─────────────────────────────────────────┘
                            │
                            ▼
┌─────────────────────────────────────────────────────────────────────┐
│                  SCREEN FOR CONTRAINDICATIONS                       │
│                                                                     │
│  ABSOLUTE CONTRAINDICATIONS:                                        │
│  • Penetrating wound (esp. gunshot)                                 │
│  • Injury > 8 hours old                                             │
│  • Peripheral nerve / root injury (brachial plexus, cauda equina)  │
│  • Age < 13 years                                                   │
│  • Pregnancy                                                        │
│  • Concomitant active infection                                     │
│  • Uncontrolled diabetes mellitus                                   │
└───────────────────────────┬─────────────────────────────────────────┘
                            │
                     No contraindication?
                            │
                            ▼
┌─────────────────────────────────────────────────────────────────────┐
│              ADMINISTER LOADING BOLUS (BOTH ARMS)                   │
│        Methylprednisolone 30 mg/kg IV over 15 minutes               │
│              Then wait 45 minutes (pause phase)                     │
└───────────────────────────┬─────────────────────────────────────────┘
                            │
                            ▼
            ┌───────────────────────────────┐
            │  TIME SINCE INJURY?           │
            └───────┬───────────────┬───────┘
                    │               │
            < 3 hours           3 - 8 hours
                    │               │
                    ▼               ▼
        ┌───────────────┐   ┌───────────────────┐
        │  NASCIS II    │   │    NASCIS III     │
        │  24-hour arm  │   │    48-hour arm    │
        │               │   │                   │
        │ MPSS 5.4 mg/  │   │  MPSS 5.4 mg/    │
        │  kg/hr x 23h  │   │   kg/hr x 47h    │
        └───────┬───────┘   └─────────┬─────────┘
                │                     │
                ▼                     ▼
        Total = 24 hours      Total = 48 hours

Summary of Dosing

Parameter	Value
Loading bolus dose	30 mg/kg methylprednisolone IV
Bolus infusion duration	Over 15 minutes
Pause between bolus & maintenance	45 minutes
Maintenance infusion rate	5.4 mg/kg/hr IV
If started < 3 hours after injury	Continue maintenance for 23 hours (total = 24h)
If started 3-8 hours after injury	Continue maintenance for 47 hours (total = 48h)
If > 8 hours after injury	Do NOT give - not beneficial and potentially harmful

Tirilazad Mesylate (NASCIS III, Third Arm)

A 21-aminosteroid (lazaroid) - potent inhibitor of lipid peroxidation without glucocorticoid activity
Given at 2.5 mg/kg IV every 6 hours for 48 hours (after the standard MPSS bolus)
Post-hoc analysis: similar efficacy to 24-hour MPSS if started within 3 hours
Advantage: Fewer infectious complications than 48-hour MPSS
Current status: Not widely adopted; considered equivalent but not superior

Complications of High-Dose MPSS

These were documented in all three NASCIS trials and are the primary reason the regimen remains controversial:

Complication	Significance
Severe sepsis	Significantly higher in 48h arm
Severe pneumonia	Significantly higher in 48h arm
Wound infection and delayed healing	Increased risk
Deep vein thrombosis / Pulmonary embolism	Increased risk
GI bleeding / peptic ulceration	Requires GI prophylaxis
Hyperglycemia	Requires monitoring
Death	No significant difference (p = 0.97)

GI prophylaxis (PPI/H2 blocker) should always be co-administered with the NASCIS regimen.

Criticisms of the NASCIS Trials

Post-hoc subgroup analysis - primary outcomes were negative; benefits only emerged in subgroups defined after data collection
Artificiality of the 3-hour and 8-hour time windows - methodologically questioned
Imbalance in injury severity between treatment groups
Small effect size for neurologic improvement vs large complication burden
Multiple reanalyses by independent authors failed to replicate the significance

Current Guidelines (2025 Status)

Organization	Recommendation
AANS/CNS 2013	Recommended AGAINST methylprednisolone use in acute SCI
AOSpine / AANS/CNS (recent)	Weak evidence - 24h infusion may be offered as an option within 8 hours; 48h infusion is not recommended
Rockwood & Green (2025)	Use only in carefully selected patients after informed discussion of risks and benefits

Key quote from AANS/CNS 2013: "There is no consistent or compelling medical evidence of any beneficial effect of methylprednisolone in acute SCI."

Despite this, some centers continue use due to medicolegal concerns - surveys show the majority of SCI patients still prefer to receive MPSS even for small potential benefits.

Memory Aid

"30-45-5.4" Rule:

30 mg/kg bolus
45 minute pause
5.4 mg/kg/hr maintenance

"3 and 8" Rule:

Within 3 hours → 24-hour regimen
3 to 8 hours → 48-hour regimen
Beyond 8 hours → Do NOT give

Quick Summary Table

Feature	NASCIS II	NASCIS III
Year	1990	1997
Arms	MPSS vs Naloxone vs Placebo	MPSS 24h vs MPSS 48h vs Tirilazad 48h
n	427	499
Positive primary outcome	No	No
Key post-hoc finding	<8h → better motor	3-8h → 48h arm better at 6 months
Window for 24h regimen	<8h (and <3h per NASCIS III)	<3h
Window for 48h regimen	-	3-8h

Sources:

Miller's Review of Orthopaedics, 9th Edition, pp. 791-792
Rockwood and Green's Fractures in Adults, 10th Edition (2025), pp. 2418-2420
Tintinalli's Emergency Medicine, Comprehensive Study, pp. 1754-1755 (Table 258-8)
Schwartz's Principles of Surgery, 11th Edition, p. 1874
Bracken MB et al. NASCIS III. JAMA. 1997;277(20):1597-604. PMID: 9168289

This is a shared conversation. Sign in to Orris to start your own chat.